Pharmaceutical Supply – Scopolamine Transdermal Patches

The contract involves the supply and delivery of FDA-approved Scopolamine Transdermal Systems, specifically 1 MG patches in sets of four, designed to meet strict military packaging, labeling, and shelf-life standards. The product must have no less than 50% of its shelf life remaining upon delivery to the specified destination. The performance location for this contract is Fort Bragg, and the solicitation is handled by the Department of Defense under the Medical Supply Chain Pharmacy FSA. This procurement is categorized under the NAICS code 325412, which pertains to pharmaceutical manufacturing. The solicitation was posted on May 27, 2026, with a response deadline of June 2, 2026. While the contract is structured as a subcontract, no specific set-aside designations or organization types are identified. The opportunity is accessible through the Defense Industrial Base Single Stock Fund (DIBBS) platform, reflecting its nature as a critical pharmaceutical supply requirement for military medical operations.